rs6882

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_022356.4(P3H1):​c.*257G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.666 in 557,178 control chromosomes in the GnomAD database, including 124,843 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 31661 hom., cov: 34)
Exomes 𝑓: 0.68 ( 93182 hom. )

Consequence

P3H1
NM_022356.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.225

Publications

11 publications found
Variant links:
Genes affected
P3H1 (HGNC:19316): (prolyl 3-hydroxylase 1) This gene encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Three alternatively spliced transcript variants encoding different isoforms have been described. Other variants may exist, but their biological validity has not been determined. [provided by RefSeq, Aug 2011]
P3H1 Gene-Disease associations (from GenCC):
  • osteogenesis imperfecta type 8
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.754 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
P3H1NM_022356.4 linkc.*257G>A 3_prime_UTR_variant Exon 15 of 15 ENST00000296388.10 NP_071751.3 Q32P28-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
P3H1ENST00000296388.10 linkc.*257G>A 3_prime_UTR_variant Exon 15 of 15 1 NM_022356.4 ENSP00000296388.5 Q32P28-1

Frequencies

GnomAD3 genomes
AF:
0.642
AC:
97670
AN:
152084
Hom.:
31658
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.556
Gnomad AMI
AF:
0.620
Gnomad AMR
AF:
0.652
Gnomad ASJ
AF:
0.662
Gnomad EAS
AF:
0.708
Gnomad SAS
AF:
0.775
Gnomad FIN
AF:
0.653
Gnomad MID
AF:
0.652
Gnomad NFE
AF:
0.675
Gnomad OTH
AF:
0.642
GnomAD4 exome
AF:
0.676
AC:
273612
AN:
404976
Hom.:
93182
Cov.:
2
AF XY:
0.682
AC XY:
143909
AN XY:
211116
show subpopulations
African (AFR)
AF:
0.557
AC:
6585
AN:
11818
American (AMR)
AF:
0.659
AC:
11334
AN:
17198
Ashkenazi Jewish (ASJ)
AF:
0.661
AC:
8405
AN:
12722
East Asian (EAS)
AF:
0.654
AC:
18752
AN:
28692
South Asian (SAS)
AF:
0.781
AC:
29748
AN:
38072
European-Finnish (FIN)
AF:
0.667
AC:
17991
AN:
26986
Middle Eastern (MID)
AF:
0.661
AC:
1209
AN:
1828
European-Non Finnish (NFE)
AF:
0.672
AC:
163716
AN:
243714
Other (OTH)
AF:
0.663
AC:
15872
AN:
23946
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
4156
8313
12469
16626
20782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
770
1540
2310
3080
3850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.642
AC:
97706
AN:
152202
Hom.:
31661
Cov.:
34
AF XY:
0.644
AC XY:
47919
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.556
AC:
23056
AN:
41498
American (AMR)
AF:
0.652
AC:
9977
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.662
AC:
2298
AN:
3470
East Asian (EAS)
AF:
0.708
AC:
3666
AN:
5178
South Asian (SAS)
AF:
0.775
AC:
3744
AN:
4832
European-Finnish (FIN)
AF:
0.653
AC:
6915
AN:
10592
Middle Eastern (MID)
AF:
0.653
AC:
192
AN:
294
European-Non Finnish (NFE)
AF:
0.675
AC:
45937
AN:
68010
Other (OTH)
AF:
0.641
AC:
1357
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1829
3657
5486
7314
9143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.661
Hom.:
42265
Bravo
AF:
0.637
Asia WGS
AF:
0.736
AC:
2559
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Osteogenesis imperfecta type 8 Benign:2
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Osteogenesis Imperfecta, Recessive Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
5.4
DANN
Benign
0.77
PhyloP100
0.23
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6882; hg19: chr1-43212111; API